Table 2.
Analyte | Electrode * | Technique * | Linear Range (µmol L−1) | LOD (µmol L−1) | Samples | Reference |
---|---|---|---|---|---|---|
8-hydroxyguanine | MWCNTs-COOH/SPCE | DPV | 3.0 × 10−1–12 | 5.7 × 10−1 | Electrochemical monitoring of stability of 8-hydroxyguanine | [125] |
Antihistamine drug bilastine (BIL) | MWCNTs-SPCE | CV and LSV | 2.29 × 10−1–4.58 | 1.3 × 10−1 | Pharmaceutical formulations and urine | [119] |
Bilirubin | MWCNTs-SPCE and GO-SPCE | CV | MWCNTs 0.5–500 and graphene 0.1–600 | MWCNTs (3.0 ± 0.22) × 10−4 and Graphene (1.0 ± 0.18) × 10−4 | Blood serum | [120] |
Catechol | f-MWCNTs/SPCE | CV | 8.0 × 10−2–725 | 3.0 × 10−2 | Water | [113] |
Caffeic acid | MWCNT/SPEs | DPV | 2.0–50.0 | 0.2 | Tea | [124] |
Cd(II) | CuF/GCE and CuF/CN/SPE | ASV | 5 × 10−4–5 × 10−1 for CuF/GCE and 3 × 10−4–3 × 10−1 for CuF/CN/SPE | CuF/GCE: 1.7 × 10−4 and CuF/CN/SPE: 1.3 × 10−4 | Water | [126] |
Cd(II) and Pb(II) | RGO-MWCNT-AuNP/SPE | SWSV | 8.90 × 10−3–7.12 × 10−1 for Cd(II) and 4.83 × 10−3–3.86 × 10−1 for Pb(II) | 6.23 × 10−3 for Cd(II) and 1.45 × 10−3 for Pb(II) | Soil | [114] |
Diclofenac | SPCE/MWCNTs-COOH | DPAdSV | 1.0 × 10−4–1.0 × 10−2 | 2.8 × 10−5 | Water | [127] |
Dopamine | mMWCNTs/SPE | CV | 5–8 | 4.3 × 10−1 | Spiked human blood serum | [121] |
Dopamine | Modified GCE and SPCE with sodium bis[N-2-oxyphenyl-5-bromosalicylideneiminato-ONO] ruthenate(III), MWCNTs and Nafion | CV, DPV, and flow injection amperometry | up to 326 | (7.18 ± 2.61) × 10−1 | Ampoules of dopamine hydrochloride | [128] |
Estriol | CNT-SPCE | Amperommetry; CV | 1–1.0 × 103 | 5.3 × 10−1 | Commercial pharmaceutical formulation | [123] |
H2O2 | SPCE/PAKB NPs/CNTs | CV and amperometry | 20–6.48 × 103 | 2.7 | Milk and water | [129] |
Imidacloprid | IL-SWCNT/SPC | LSV; CV | 11–5.75 | 8.2 × 10−1 | Spiked commercial honey | [130] |
Indole | MWCNTs-CS/SPCE | CV; DPV | 4.27 × 10−2–8.54 × 10−1 | 4.27 × 10−3 | Plasma | [131] |
K4FeCN6, H2O2 and nicotinamide adenine dinucleotide (NAD+/NADH) | MWCNT/GP/SPCE | CV | 10–1.0 × 103 | 3.1 for K4FeCN6, 7.1 × 106 for H2O2 and 3.6 for NADH | --- | [132] |
Kojic acid | MWCNTs-CS/SPCE | DPV | 20–5.0 × 103 | 16 | Apple vinegar and Rice vinegar | [133] |
Levothyroxine (LT4) | SPCEs, containing CNTs, graphene, and AuNPs individually | DPV | 5.0 × 10−4–3.0 × 10−3 (for CNT) | 1.5 × 10−1 | Diluted fetal bovine serum | [134] |
Methyldopa | AuNPs/CNT/SPCE | Flow injection amperometry | 2.0 × 10−1–100 | 1.0 × 10−1 | Pharmaceutical and urine | [135] |
Ochratoxin | SPE on PET and PDMS, coated with SWCNTs and immobilized with anti-OTA antibodies. | CV | 2.48 × 10−5–2.48 × 10−3 | PET 1.98 × 10−4 and PDMS 3.22 × 10−4 | Grape juice and wine | [136] |
Paracetamol, Ibuprofen and Caffeine | SPCE, SPCNTE, SPCNFE, and SPGPHE | DPV | 1.32 × 10−2–6.62 × 10−1 for PA, 9.70 × 10−3–4.85 × 10−1 for IB and 1.03 × 10−2–5.15 × 10−1 for CF | 5.95 × 10−1 for PA, 10.7 for IB, and 1.03 for CF | Spikes tap water and hospital wastewater | [137] |
Paraquat | SPCE-CNT/Nafion | CV; DPV | 5.4 × 10−1–4.3 | 1.7 × 10−1 | Natural water | [118] |
Piperazine | CNTs-Nafion/GCE and SPCE | LSV; DPV | 4.0 × 10−1–12 | 1.1 × 10−1 | Human Plasma | [138] |
Polyphenols content | GCE and SWCNTs-SPCE | SWV | --- | --- | Red wines | [139] |
Secretion of electroactive metabolite(s) in the extracellular matrix | MWCNTs/SPE | CV | 1.0 × 105–1.1 × 106 OD600 | 1.0 × 105 OD600 | Bacterial cell suspensions | [140] |
Stimulant modafinil | SPE-CNT | AdSWV | 7.5–300 | 2 | Saliva | [122] |
Tl(I) | SPCE/MWCNTs/BiF | ASV | 1.0 × 10−2–1 | 2.8 × 10−3 | Spiked water from the Vistula River | [115] |
Thrombin | SWCNTs/SPCE | CV | 1.0 × 10−1–1 | 2.0 × 10−5 | --- | [141] |
U(VI) | MWCNTs/SPE (electrode III) and IL-MWCNTs/SPE (electrode VII) | Potentiometry | 10–1.0 × 105 for electrode III and 4.7 × 10−1–1.0 × 105 for electrode VII | 10 for electrode III and 4.7 × 10−1 for electrode VII | Water | [116] |
Zn(II), Pb(II) and Cu(II) | SPCE/CNTs/AuNP | DPASV | Zn2+: 1.51 × 10−2–1.84; Pb2+: 4.78 × 10−2–5.79 × 10−1, and Cu2+: 1.56 × 10−2–1.89 × 10−1 | Zn2+: 1.53 × 10−2–5.35 × 10−2; Pb2+: 7.24 × 10−3–2.41 × 10−2; Cu2+: 1.57 × 10−3–5.19 × 10−3 for Cu2+ | --- | [117] |
* The explanations of the abbreviations in Table 2 can be found in the Supplementary Materials.